USP18 and urinary bladder carcinoma: These insights not only enhance our understanding of the genetic factors in bladder cancer but also open new avenues for the development of targeted therapies and diagnostic tools, particularly in the context of the PD-L1/PD-1 axis and its regulation by USP18.